Delivery Order V797D60724-75A50322F80028
Award Date 9/14/22
Potential Completion Date 3/31/25
Potential Value $60M
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Medical Supply Chain of the Department of Defense to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The contract is for the delivery of oseltamivir phosphate, an antiviral medication, with a ceiling value of $149,340.18. The contract is a firm-fixed price delivery order placed under an existing vehicle, with an ultimate completion date of September 21, 2017. No set-aside designation was used. Genentech...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The $414,641.57 firm-fixed-price order is part of a larger indefinite delivery contract with DLA valued at $27.9 million, which enables the agency to place delivery orders for medical supplies and critical pharmaceuticals to support the Department of Defense's global health logistics network. Genentech also holds a $4.9...
- The Defense Logistics Agency Troop Support Medical awarded a $343,886.48 firm fixed-price delivery order contract to Genentech USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer. This order is placed under an existing contract vehicle and supports the agency's requirement for pharmaceutical products. Genentech holds various indefinite delivery contracts and Federal Supply Schedule agreements with government agencies, allowing them to efficiently procure vital medicines like the...
- This federal contract award, valued at $543,591.57, was issued by the Defense Logistics Agency (DLA) under contract number SPE2D021D0005|SPE2D024F0246 to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The award is for the delivery of unspecified "Other Medical" supplies and has a period of performance through June 23, 2025. Genentech holds several large, flexible contract vehicles with federal agencies, including a $4.9 billion Federal...
- This is a $398,047.11 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor Genentech USA, Inc. The contract provides for the delivery of other medical supplies, with a performance location in South San Francisco, California. Genentech is a foreign-owned, for-profit organization that manufactures pharmaceutical products. The contract does not utilize a set-aside designation. Genentech holds multiple indefinite delivery and Federal Supply...
- This is a $92,304 firm-fixed-price delivery order awarded by the Department of Defense's Medical Supply Chain to Genentech USA, Inc. for the pharmaceutical product oseltamivir phosphate. The contract has no set-aside designation. Genentech is a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics that provides a wide range of products to federal agencies through various contract vehicles, including a $4.9 billion Federal Supply Schedule with the Department of Veterans...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate, an antiviral medication. The contract has a firm fixed price, with a ceiling value of $88,842.60, and was awarded on September 8, 2017 with a completion date of September 10, 2018. The contract was not set aside for any special designation. Genentech holds several key contract vehicles with...
- This federal contract award, SPE2DP18D0011|SPE2DP18F6081, was issued by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $93,573.18 firm-fixed-price delivery order is for the supply of the antiviral medication oseltamivir phosphate, also known as Tamiflu. This award does not have a set-aside designation. Genentech is an established contractor providing pharmaceuticals and biologics to federal agencies through various contract...
- The Defense Logistics Agency Troop Support Medical awarded a $116,303.04 delivery order contract to Genentech USA, Inc. for the antiviral medication oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of pharmaceuticals that has held numerous indefinite delivery contracts and blanket purchase agreements with various federal agencies for critical biologic medicines. This contract does not utilize any set-asides and will be performed at Genentech's facility in South San...
- This is a $102,842.04 delivery order awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a foreign-owned for-profit biopharmaceutical manufacturer. The order is for the antiviral drug oseltamivir phosphate, with a completion date of September 24, 2019. The contract utilizes a firm-fixed price pricing arrangement and has no set-aside designation. Genentech has previously supplied pharmaceuticals such as Tamiflu and Activase to federal agencies including the...